NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









iFAST Diagnostics

iFAST Diagnostics

Private
United KingdomHealthcare & Life Scienceshttps://ifastdiagnostics.com/

Last Round

Early Funding

May 28, 2026

Total Funding Raised

$15.25M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

iFAST Diagnostics is a biotechnology company that has developed a rapid antimicrobial susceptibility testing (AST) system to provide results in under three hours.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2G

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

antimicrobial susceptibility testingASTrapid diagnosticsantimicrobial resistanceAMRsepsis diagnosticsimpedance flow cytometrymicrofluidicsin-vitro diagnosticsIVDsuperbug detectionphenotypic ASTsame-shift diagnosticsminimum inhibitory concentrationMICdiagnostic consumablesrazor and blade model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iFAST Diagnostics Comparables

Compare iFAST Diagnostics with similar companies based on industry and business-model similarity.

iFAST Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

iFAST Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 28, 2026
SeedNov 5, 2024
Pre SeedFeb 16, 2023

Key People

Founding team and executive leadership

Toby King

Chief Executive Officer

Executive Team

iFAST Diagnostics Investors

Notable investors and investment history

iFAST Diagnostics investors
InvestorRounds
OKG CapitalEarly Funding
QantXSeed, Early Funding, Pre Seed
Cambridge Capital GroupEarly Funding
Raw VenturesSeed, Early Funding
UK Innovation & Science Seed FundPre Seed, Seed
Kadmos CapitalPre Seed, Seed
Meridian Health VenturesPre Seed, Seed, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 28, 2026

    $6.35M raised, led by Meridian Health Ventures.

  • May 16, 2026

    Monthly visitors grew 33% MoM.

iFAST Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

iFAST Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iFAST Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited Kingdom
Employee Range25
Year Founded2022
Last FundingMay 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.